BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1228 related articles for article (PubMed ID: 8924324)

  • 21. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].
    Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; García López R; Navascues CA; Suárez González A; Díaz Alvarez G; González Bernal A; Palacios Galán A; Altadill Arregui A; Vizoso F
    Gastroenterol Hepatol; 2000; 23(7):322-7. PubMed ID: 11002532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum.
    Annese V; Andreoli A; Astegiano M; Campieri M; Caprilli R; Cucchiara S; D'Incà R; Giaccari S; Iaquinto G; Lombardi G; Napolitano G; Pera A; Riegler G; Valpiani D; Andriulli A;
    Am J Gastroenterol; 2001 Oct; 96(10):2939-45. PubMed ID: 11693330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA antigens in inflammatory bowel disease.
    Smolen JS; Gangl A; Polterauer P; Menzel EJ; Mayr WR
    Gastroenterology; 1982 Jan; 82(1):34-8. PubMed ID: 6796456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
    Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
    Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.
    Papa A; Pola R; Flex A; Danese S; Armuzzi A; Gaetani E; Guidi L; De Vitis I; Urgesi R; Grillo A; Serricchio M; Proia AS; Fedeli G; Gasbarrini G; Pola P; Gasbarrini A
    Dig Liver Dis; 2004 Aug; 36(8):528-32. PubMed ID: 15334773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
    Kull E; Beau P
    Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, course and socio-economic influence of inflammatory bowel disease.
    Binder V
    Schweiz Med Wochenschr; 1988 May; 118(20):738-42. PubMed ID: 3387970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of ulcerative colitis and Crohn's disease in Turkey.
    Ozin Y; Kilic MZ; Nadir I; Cakal B; Disibeyaz S; Arhan M; Dagli U; Tunc B; Ulker A; Sahin B
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):157-62. PubMed ID: 19565044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].
    Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G
    Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defense mechanisms in inflammatory bowel disease.
    Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
    J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
    Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
    Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commonalities in the time trends of Crohn's disease and ulcerative colitis.
    Delcò F; Sonnenberg A
    Am J Gastroenterol; 1999 Aug; 94(8):2171-6. PubMed ID: 10445545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis associated with ulcerative colitis and Crohn's disease.
    Cohen AD; Dreiher J; Birkenfeld S
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):561-5. PubMed ID: 19207663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.